UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000051789 |
|---|---|
| Receipt number | R000059095 |
| Scientific Title | Factors that induce delirium in patients with cancer: a scoping review |
| Date of disclosure of the study information | 2023/08/02 |
| Last modified on | 2023/09/02 16:36:30 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Factors that induce delirium in patients with cancer: a scoping review
Acronym
Factors that induce delirium in patients with cancer: a scoping review
Scientific Title
Factors that induce delirium in patients with cancer: a scoping review
Scientific Title:Acronym
Factors that induce delirium in patients with cancer: a scoping review
Region
| Japan |
Condition
Condition
Cancer
Classification by specialty
| Hematology and clinical oncology | Psychiatry |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To extract factors of delirium in adult cancer patients and identify the magnitude of effect of various factors individually
Basic objectives2
Others
Basic objectives -Others
To map the various factors that trigger delirium in patients with cancer
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Factors of delirium in patients with cancer
Key secondary outcomes
The extent to which each of the various factors of delirium in patients with cancer is involved in the development of delirium
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with cancer (more than or equal to 80%)
Key exclusion criteria
1. Case report
2. Case series of less than 10 cases
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Koji |
| Middle name | |
| Last name | Sugano |
Organization
Juntendo Tokyo Koto Geriatric Medical Center
Division name
Division of Respiratory Medicine
Zip code
136-0075
Address
3-3-20, Shinsuna, Koto-ku, Tokyo
TEL
03-5632-3111
ksugano@juntendo.ac.jp
Public contact
Name of contact person
| 1st name | Koji |
| Middle name | |
| Last name | Sugano |
Organization
Juntendo Tokyo Koto Geriatric Medical Center
Division name
Division of Respiratory Medicine
Zip code
136-0075
Address
3-3-20, Shinsuna, Koto-ku, Tokyo
TEL
03-5632-3111
Homepage URL
ksugano@juntendo.ac.jp
Sponsor or person
Institute
Juntendo University
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
N/A
Address
N/A
Tel
N/A
N/A
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 08 | Month | 02 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2023 | Year | 07 | Month | 31 | Day |
Date of IRB
Anticipated trial start date
| 2023 | Year | 09 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 07 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Data sources and search strategy
We will conduct a scoping review to identify factors contributing to delirium in cancer patients. This scoping review will be conducted using the electronic databases, Medical Journal Web Edition ver. 5, Cochrane Library, and MEDLINE, with the keywords "delirium," "cancer," and "risk factor," for all literature reported up to 2023/08/31.
Selection of studies in included studies
Two review authors will independently check to ensure that studies meet the inclusion criteria. Any discrepancies in study selection will be resolved by discussion or discussion with a third author. The risk of bias for each study is assessed independently by the same two investigators in accordance with the Minds Practice Guidelines Development Manual 2020 ver. 3.0.
Management information
Registered date
| 2023 | Year | 08 | Month | 02 | Day |
Last modified on
| 2023 | Year | 09 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059095
